Chemed Co. (NYSE:CHE) CEO Sells $1,011,520.00 in Stock

Chemed Co. (NYSE:CHEGet Rating) CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 21st. The shares were sold at an average price of $505.76, for a total value of $1,011,520.00. Following the completion of the transaction, the chief executive officer now owns 121,264 shares in the company, valued at approximately $61,330,480.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Chemed Stock Performance

Shares of Chemed stock opened at $513.10 on Thursday. The business’s fifty day simple moving average is $466.29 and its 200 day simple moving average is $476.80. The firm has a market capitalization of $7.63 billion, a P/E ratio of 29.81, a price-to-earnings-growth ratio of 3.89 and a beta of 0.54. Chemed Co. has a 12 month low of $430.16 and a 12 month high of $539.87. The company has a current ratio of 0.67, a quick ratio of 0.63 and a debt-to-equity ratio of 0.13.

Chemed (NYSE:CHEGet Rating) last issued its quarterly earnings results on Monday, October 31st. The company reported $4.74 EPS for the quarter, topping analysts’ consensus estimates of $4.65 by $0.09. Chemed had a return on equity of 44.29% and a net margin of 12.31%. The business had revenue of $526.47 million for the quarter, compared to analyst estimates of $527.05 million. During the same period last year, the company posted $5.06 earnings per share. Chemed’s quarterly revenue was down 2.3% compared to the same quarter last year. As a group, analysts anticipate that Chemed Co. will post 18.72 EPS for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 5th. Shareholders of record on Monday, November 14th will be given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Thursday, November 10th. Chemed’s dividend payout ratio is currently 8.83%.

Analyst Ratings Changes

A number of brokerages recently commented on CHE. StockNews.com lowered Chemed from a “strong-buy” rating to a “buy” rating in a report on Wednesday, November 9th. Royal Bank of Canada lifted their price target on Chemed from $541.00 to $545.00 and gave the stock an “outperform” rating in a report on Thursday, November 3rd.

Institutional Trading of Chemed

A number of large investors have recently bought and sold shares of CHE. Signaturefd LLC increased its position in Chemed by 69.6% in the first quarter. Signaturefd LLC now owns 95 shares of the company’s stock worth $48,000 after buying an additional 39 shares during the last quarter. Atria Investments LLC increased its position in Chemed by 6.5% in the first quarter. Atria Investments LLC now owns 3,702 shares of the company’s stock worth $1,875,000 after buying an additional 227 shares during the last quarter. FDx Advisors Inc. grew its position in shares of Chemed by 4.7% in the first quarter. FDx Advisors Inc. now owns 2,900 shares of the company’s stock valued at $1,469,000 after purchasing an additional 131 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of Chemed by 11.0% in the first quarter. Envestnet Asset Management Inc. now owns 50,152 shares of the company’s stock valued at $25,404,000 after purchasing an additional 4,972 shares in the last quarter. Finally, Prospera Financial Services Inc purchased a new position in shares of Chemed in the first quarter valued at $138,000. 90.42% of the stock is owned by hedge funds and other institutional investors.

Chemed Company Profile

(Get Rating)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.